Brief: Chemomab Therapeutics Reports Q3 Loss Of $0.035 Per Share

Chemomab Therapeutics

11/11/2022 11:06

Nov 11 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB THERAPEUTICS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * CHEMOMAB THERAPEUTICS LTD Q3 LOSS PER SHARE $0.035
    * CHEMOMAB THERAPEUTICS LTD - COMPANY CURRENTLY EXPECTS ITS
RUNWAY
TO LAST THROUGH YEAR-END 2023

Source text for Eikon:  ID:nPn2hTKhLa 
Further company coverage:  CMMB.O 
 ((Reuters.Briefs@thomsonreuters.com;))